Literature DB >> 6405665

The relationship of phenotype changes in Pseudomonas aeruginosa to the clinical condition of patients with cystic fibrosis.

A Penketh, T Pitt, D Roberts, M E Hodson, J C Batten.   

Abstract

Strains of Pseudomonas aeruginosa, isolated from the sputum of relatively fit patients with cystic fibrosis (CF) who had been recently colonized by the organism, showed typical cultural and serologic characteristics. The majority of strains of P. aeruginosa isolated from CF patients with chronic bronchopulmonary infection had 3 distinctive features, loss of 0 serotype reaction, expression of a new somatic antigen, and sensitivity to normal human serum. Patients with organisms with one or two of these features were more severely affected by the disease. The appearance of these variants may represent a critical stage in the progression of CF.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6405665     DOI: 10.1164/arrd.1983.127.5.605

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  46 in total

1.  Correlation of wbiI genotype, serotype, and isolate source within species of the Burkholderia cepacia complex.

Authors:  Arlene D Vinion-Dubiel; Theodore Spilker; Charles R Dean; Henri Monteil; John J LiPuma; Joanna B Goldberg
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

2.  Heterogeneity, persistence, and distribution of Pseudomonas aeruginosa genotypes in cystic fibrosis patients.

Authors:  M Fegan; P Francis; A C Hayward; J A Fuerst
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

3.  Adherence to and penetration of human intestinal Caco-2 epithelial cell monolayers by Pseudomonas aeruginosa.

Authors:  Y Hirakata; K Izumikawa; T Yamaguchi; S Igimi; N Furuya; S Maesaki; K Tomono; Y Yamada; S Kohno; K Yamaguchi; S Kamihira
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

4.  Growth-dependent alterations in production of serotype-specific and common antigen lipopolysaccharides in Pseudomonas aeruginosa PAO1.

Authors:  E J McGroarty; M Rivera
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

5.  Enzyme-linked immunosorbent assay for detection of Pseudomonas aeruginosa H (flagellar) antigen.

Authors:  T C Montie; T R Anderson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-04       Impact factor: 3.267

6.  Revised pyocin typing method for Pseudomonas aeruginosa.

Authors:  J A Fyfe; G Harris; J R Govan
Journal:  J Clin Microbiol       Date:  1984-07       Impact factor: 5.948

7.  Interaction of gentamicin with the A band and B band lipopolysaccharides of Pseudomonas aeruginosa and its possible lethal effect.

Authors:  J L Kadurugamuwa; J S Lam; T J Beveridge
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

8.  Auxotrophic variants of Pseudomonas aeruginosa are selected from prototrophic wild-type strains in respiratory infections in patients with cystic fibrosis.

Authors:  A L Barth; T L Pitt
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

Review 9.  Microbiology of airway disease in patients with cystic fibrosis.

Authors:  P H Gilligan
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

10.  Pseudomonas aeruginosa population structure revisited.

Authors:  Jean-Paul Pirnay; Florence Bilocq; Bruno Pot; Pierre Cornelis; Martin Zizi; Johan Van Eldere; Pieter Deschaght; Mario Vaneechoutte; Serge Jennes; Tyrone Pitt; Daniel De Vos
Journal:  PLoS One       Date:  2009-11-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.